|
2025
|
Invention
|
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use... |
|
|
Invention
|
Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin.... |
|
|
Invention
|
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation.
The disclo... |
|
|
Invention
|
Salt forms of bis(3-(2-(dimethylamino)ethyl)-1 h-indol-4-yl) 3,3'¬oxydipropionate.
The present d... |
|
|
Invention
|
Salt forms of bis(3-(2-(dimethylamino)ethyl)-1h-indol-4-yl) 3,3'-oxydipropionate. The present dis... |
|
|
Invention
|
Scalable methods of manufacturing psilocybin. The present disclosure provides methods of manufact... |
|
|
Invention
|
Scalable methods of manufacturing psilocybin.
The present disclosure provides methods of manufac... |
|
2024
|
Invention
|
Systems and methods for generating state-based responses based on text data and speech data. In a... |
|
|
Invention
|
Systems and methods for facilitating conversation based on text data and speech data. A method in... |
|
|
Invention
|
3-(2-(dimethylamino)ethyl)-1h-indol-4-yl oligomeric derivatives. Provided herein are compounds of... |
|
|
Invention
|
3-(2-(dimethylamino)ethyl)-1h-indol-4-yl derivatives. Provided herein are compounds of Formula (I... |
|
|
Invention
|
3-(2-(dimethylamino)ethyl)-1h-indol-4-yl oligomeric derivatives.
Provided herein are compounds o... |
|
|
Invention
|
3-(2-(dimethylamino)ethyl)-1h-indol-4-yl derivatives.
Provided herein are compounds of Formula (... |
|
|
G/S
|
Pharmaceuticals; pharmaceutical preparations; psychotropics;
psychoactive medicines; psychedelic... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of mental health conditions; Pharmaceutical prepara... |
|
|
G/S
|
Pharmaceuticals for the treatment of mental health conditions; Pharmaceutical preparations for th... |
|
|
G/S
|
Pharmaceuticals; Pharmaceutical preparations; Psychotropics; Psychoactive medicines; Psychedelic ... |
|
2023
|
G/S
|
Pharmaceuticals for the treatment of mental health conditions, namely, depression, anxiety, bipol... |
|
|
Invention
|
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin. ... |
|
|
G/S
|
Downloadable software in the nature of a mobile application
for recording and creating audio and... |
|
|
G/S
|
Downloadable software in the nature of a mobile application for recording and creating audio and ... |
|
|
Invention
|
Computing n-dimensional sentiment using a large language model.
Approaches for generating predic... |
|
|
Invention
|
Computing n-dimensional sentiment using a large language model. Approaches for generating predict... |
|
|
Invention
|
Psilocybin therapy for treatment resistant depression.
Approaches for predicting a response to a... |
|
|
Invention
|
Predicting response to psilocybin therapy for treatment resistant depression. Approaches for pred... |
|
|
Invention
|
Processes for the production of tryptamines.
Disclosed herein are prokaryotic and eukaryotic mic... |
|
|
G/S
|
Downloadable software in the nature of a mobile application
to recognize, record, transcribe, an... |
|
|
G/S
|
Downloadable software in the nature of a mobile application to recognize, record, transcribe, and... |
|
2022
|
Invention
|
Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-r... |
|
|
Invention
|
Apparatuses, systems, and methods for biomarker collection, bi-directional patient communication ... |
|
|
Invention
|
Apparatuses, systems, and methods for a real time bioadaptive stimulus environment.
Approaches f... |
|
|
Invention
|
Apparatuses, systems, and methods for a real time bioadaptive stimulus environment. Approaches fo... |
|
|
Invention
|
Intelligent transcription and biomarker analysis.
Approaches for transcribing, translating, revi... |
|
|
Invention
|
Intelligent transcription and biomarker analysis. Approaches for transcribing, translating, revie... |
|
|
Invention
|
Treatment of treatment resistant depression with psilocybin. The disclosure provides methods for ... |
|
|
G/S
|
Downloadable software in the nature of a mobile application
for users to send, receive, and acce... |
|
|
G/S
|
Downloadable software in the nature of a mobile application for users to send, receive, and acces... |
|
|
Invention
|
Fluorinated tryptamine compounds, analogues thereof, and methods using same.
The present disclos... |
|
|
Invention
|
Psilocybin compositions, methods of making and methods of using the same.
The present disclosure... |
|
|
Invention
|
Psilocybin compositions, methods of making and methods of using the same. The present disclosure ... |
|
2021
|
Invention
|
Modified indole alkaloids for therapeutic uses.
Disclosed herein are enzymatic and modified host... |
|
|
G/S
|
Pharmaceuticals for the treatment of mental health conditions and disorders; psychoactive and psy... |
|
|
G/S
|
Pharmaceuticals for the treatment of mental health
conditions and disorders; psychoactive and ps... |
|
|
Invention
|
Use of benzodiazepines to increase sensitivity to psilocybin following a chronic ssri regimen.
T... |
|
|
Invention
|
Use of benzodiazepines to increase sensitivity to psilocybin following a chronic ssri regimen. Th... |
|
|
Invention
|
Novel psilocin derivatives having prodrug properties.
The present invention provides a novel gro... |
|
|
G/S
|
Downloadable computer software for monitoring and managing mental health and communicating mental... |
|
|
G/S
|
Pharmaceuticals for the treatment of mental health conditions and disorders; Psychoactive and psy... |
|
2020
|
G/S
|
Pharmaceuticals for the treatment of mental health conditions, namely, pharmaceuticals for the tr... |
|
|
G/S
|
Pharmaceuticals for the treatment of mental health
conditions; pharmaceuticals for the treatment... |
|
|
G/S
|
Therapy for the treatment of mental health conditions;
therapy for the treatment of depression; ... |
|
|
Invention
|
Treatment of depression and other various disorders with psilocybin.
The disclosure provides met... |
|
|
Invention
|
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation. The disclos... |
